Biobizkaia
Research center
German Cancer Research Center
Heidelberg, AlemaniaPublications in collaboration with researchers from German Cancer Research Center (19)
2023
-
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 7, (1861-1868), 10.1007/s00259-023-06226-z)
European Journal of Nuclear Medicine and Molecular Imaging
-
EANM enabling guide: how to improve the accessibility of clinical dosimetry
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 7, pp. 1861-1868
-
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108
-
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666
-
The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders
Brain, Vol. 146, Núm. 8, pp. 3273-3288
2021
2017
-
Building Bridges through Science
Neuron
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
2016
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2014
-
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma
Blood, Vol. 123, Núm. 8, pp. 1187-1198
2013
-
High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas
Genes Chromosomes and Cancer, Vol. 52, Núm. 2, pp. 150-155
2004
-
Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice
Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 1122-1133
1999
-
The nuclear pore complex protein Nup88 is overexpressed in tumor cells
Cancer Research, Vol. 59, Núm. 21, pp. 5408-5411